Frontiers in Pharmacology (Apr 2024)

The molecular mechanisms of peptidyl-prolyl cis/trans isomerase Pin1 and its relevance to kidney disease

  • Shukun Wu,
  • Yurong Zou,
  • Xiaoqiu Tan,
  • Shuang Yang,
  • Shuang Yang,
  • Tangting Chen,
  • Jiong Zhang,
  • Xingli Xu,
  • Xingli Xu,
  • Fang Wang,
  • Wei Li

DOI
https://doi.org/10.3389/fphar.2024.1373446
Journal volume & issue
Vol. 15

Abstract

Read online

Pin1 is a member of the peptidyl-prolyl cis/trans isomerase subfamily and is widely expressed in various cell types and tissues. Alterations in Pin1 expression levels play pivotal roles in both physiological processes and multiple pathological conditions, especially in the onset and progression of kidney diseases. Herein, we present an overview of the role of Pin1 in the regulation of fibrosis, oxidative stress, and autophagy. It plays a significant role in various kidney diseases including Renal I/R injury, chronic kidney disease with secondary hyperparathyroidism, diabetic nephropathy, renal fibrosis, and renal cell carcinoma. The representative therapeutic agent Juglone has emerged as a potential treatment for inhibiting Pin1 activity and mitigating kidney disease. Understanding the role of Pin1 in kidney diseases is expected to provide new insights into innovative therapeutic interventions and strategies. Consequently, this review delves into the molecular mechanisms of Pin1 and its relevance in kidney disease, paving the way for novel therapeutic approaches.

Keywords